Rakovina Therapeutics Inc.
RKV.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -29.35% | -11.47% | 2.02% | 9.91% | 17.04% |
| Total Depreciation and Amortization | -0.58% | -0.90% | -1.73% | -3.66% | -5.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 42.37% | 28.01% | -4.37% | -29.39% | -50.78% |
| Change in Net Operating Assets | 182.20% | 436.29% | 438.24% | -75.16% | -161.42% |
| Cash from Operations | -26.39% | 30.82% | 7.95% | 6.23% | 4.13% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | 200.00% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 28.37% | -- | -- | -- | -- |
| Cash from Financing | 34.18% | 15.54% | -- | 61,252.94% | 61,252.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.73% | 122.74% | 78.57% | 77.01% | 73.75% |